# Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke

> **NCT01016119** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 40 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Folrex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01016119
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016119, "Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01016119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*